APA (7th ed.) Citation

Buonomo, A. R., Viceconte, G., Scotto, R., De Angelis, M., Tozza, S., Manganelli, F., . . . Gentile, I. (2020). Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy. Infectious Diseases, 52(3), 216. https://doi.org/10.1080/23744235.2019.1693624

Chicago Style (17th ed.) Citation

Buonomo, A. R., G. Viceconte, R. Scotto, M. De Angelis, S. Tozza, F. Manganelli, A. G. Lanza, G. G. Di Costanzo, and I. Gentile. "Seronegative Occult HBV Reactivation Complicated with Fulminant Acute Liver Failure After Rituximab for Chronic Inflammatory Demyelinating Polyneuropathy." Infectious Diseases 52, no. 3 (2020): 216. https://doi.org/10.1080/23744235.2019.1693624.

MLA (9th ed.) Citation

Buonomo, A. R., et al. "Seronegative Occult HBV Reactivation Complicated with Fulminant Acute Liver Failure After Rituximab for Chronic Inflammatory Demyelinating Polyneuropathy." Infectious Diseases, vol. 52, no. 3, 2020, p. 216, https://doi.org/10.1080/23744235.2019.1693624.